IPOs of Ventive Hospitality and Senors Pharma received tremendous response from investors

IPO News: These days, investors' enthusiasm for IPO (Initial Public Offering) is at its peak in the Indian stock market. The IPOs of hospitality services company Ventive Hospitality Limited and drug manufacturer Senors Pharmaceuticals Limited have received tremendous response from investors. Both the companies registered great subscription, winning the trust of investors in their respective sectors.

Ventive Hospitality Limited: 9.82 times subscription

Ventive Hospitality Limited's IPO closed on Tuesday and received a total subscription of 9.82 times. According to NSE data, bids were received for 14,17,23,907 shares against the offer of 1,44,34,453 shares.

Non-Institutional Investors (NII): 13.87 times

Qualified Institutional Buyers (QIB): 9.08 times

Retail Individual Investors (RII): 5.94 times

Price Band and Anchor Investors

The price band for the IPO was fixed at ₹610-₹643 per share. The company raised ₹719 crore from anchor investors even before it opened.

Use of Funds

The company will use the proceeds from this fresh equity issue of Rs 1,600 crore to repay its debt.

Company Introduction

Ventiv Hospitality, formerly ICC Realty, is a joint venture between the US-based Blackstone Group and Pune-based Panchshil Realty.

Senors Pharmaceuticals Limited: 93.69 times subscription

Senors Pharmaceuticals Limited's Rs 582 crore IPO also received an overwhelming response. It received 93.69 times subscription till the last day.

Non-Institutional Investors (NII): 96.30 times

Qualified Institutional Buyers (QIB): 94.66 times

Retail Individual Investors (RII): 90.46 times

Price Band and Anchor Investors

The price band for the IPO was fixed at ₹372-₹391 per share. The company raised ₹261 crore from anchor investors before the launch of the IPO.

Issue Details

The IPO saw the issuance of fresh equity shares worth Rs 500 crore. Also, promoters and other shareholders raised ₹82.11 crore through an offer for sale (OFS) of 21 lakh shares.

Company Introduction

Ahmedabad-based Senors Pharmaceuticals specializes in the development and manufacturing of complex and low-service pharmaceutical products. The company is known for its specialty pharmaceutical products and its primary focus is on meeting the demand of global markets.

Conclusion

The tremendous success of the IPOs of Ventive Hospitality and Senors Pharmaceuticals shows that investor confidence in the Indian stock market remains strong. Both these companies are moving towards setting new dimensions in their respective industries. With investor interest and positive market indicators, the IPO market is expected to see even more excitement in the coming days.